mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
Tiago Azenha Rama, André Moreira, Mariana Castells
Topics & Concepts
AnaphylaxisSystemic mastocytosisMast cellMedicineCoronavirus disease 2019 (COVID-19)ImmunologyDermatologyUrticaria pigmentosaAllergyInternal medicineInfectious disease (medical specialty)DiseaseMast cells and histamineDrug-Induced Adverse ReactionsFood Allergy and Anaphylaxis Research